Integrating Botulinum Toxin and Physical Therapy for Post-Stroke Spasticity Management

When managing post-stroke spasticity, just injecting Botulinum Toxin isn't enough. The real magic happens when you pair it with targeted physical therapy. BoNT-A is our gold standard for focal spasticity, backed by GRADE A evidence, because it focally weakens overactive muscles by blocking acetylcholine release at the neuromuscular junction. This creates a crucial window, typically starting to peak around 4 weeks post-injection, where the muscle's pathological overactivity is reduced. This is your prime time to intervene with intensive, task-specific training. A 2025 systematic review of seven randomized controlled trials highlighted that while BoNT-A alone reduces tone, combining it with therapy, particularly robot-assisted therapy, can lead to greater gains in motor function, gait, and balance. The key is intensity and timing. For lower limb spasticity, think high-repetition gait training, 3-5 times a week for 4-8 weeks. For the upper limb, a similar intensity of task-oriented practice is effective. For example, after injecting the elbow flexors (e.g., Biceps Brachii, Brachialis) with 50-150 units of OnabotulinumtoxinA, you would initiate a program of active and active-assisted elbow extension exercises, focusing on reaching and object manipulation. A typical protocol would be 3 sets of 10-15 repetitions, twice daily. The evidence suggests that starting this intensive therapy about four weeks after the injection may maximize motor gains. This approach doesn't just passively reduce tone; it actively retrains the brain, leveraging neuroplasticity to forge new, more functional movement patterns.